Literature DB >> 3079611

Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.

H Kawamura, J A Berzofsky.   

Abstract

We have examined the effect of targeting an antigen to the immune system, by covalently coupling it to anti-immunoglobulin (Ig), on its efficacy for T cell stimulation in vitro and its immunogenicity for antibody production in vivo. In vitro, we compared the potency (for stimulation of a ferritin-specific T cell line) of free ferritin, ferritin coupled to goat antimouse IgM (heavy (H) chain specific), ferritin coupled to anti-IgG (H and light (L) chain specific), or ferritin coupled to anti-IgA (H chain specific), as well as a mixture of free ferritin plus goat anti-IgG. The ferritin coupled to anti-IgM or to anti-IgG (H + L), which could bind to surface Ig of B cells, stimulated T cell proliferation at concentrations of ferritin at least 10-fold lower than those required for the other forms of the antigen over the entire time course of the response, with 1000 rad-irradiated spleen cells as presenting cells. Because the goat antibodies were all of the same IgG isotype and coupling ratio, the failure of goat anti-IgA to enhance potency served as a control to exclude Fc receptor binding as the mechanism. The effect was not due to the nonspecific activation of B cells to become more efficient antigen-presenting cells, because mixtures of ferritin plus anti-IgG (H + L) had no effect, and the anti-IgG coupled to ferritin did not enhance presentation of myoglobin to a myoglobin-specific T cell line. The enhanced presentation of ferritin conjugated to goat anti-IgG (H + L) or to anti-IgM was sensitive to radiation doses greater than 2000 R, and was effective at less than one-tenth the number of spleen cells, consistent with the predominance of B cells as antigen-presenting cells for this form of the antigen rather than macrophages and dendritic cells only. When B cells and accessory cells were purified from T-depleted spleen cells, only the B cell preparation but not the accessory cell population manifested enhanced presentation of ferritin coupled to anti-IgG compared with free ferritin, and it was radiosensitive. Finally, allogeneic B cells could not mediate the enhancement in the presence of syngeneic splenic accessory cells (SAC); therefore, the enhancement was not due to shedding of immune complexes from B cells and subsequent presentation by SAC. We conclude that targeting the antigen to B cells as presenting cells greatly enhances its efficacy in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079611

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Mechanisms of transplantation immunity.

Authors:  E Simpson
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Targeting of T-B interaction using heteroconjugate antibody.

Authors:  J L Davignon; M Vallin-Davignon; P L Cohen; R A Eisenberg
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization.

Authors:  H Wang; M N Griffiths; D R Burton; P Ghazal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Cellular immune response to the antigen administered as an immune complex.

Authors:  S Marusić-Galesić; K Pavelić; B Pokrić
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

5.  STALing B cell responses with CD22.

Authors:  Craig P Chappell; Edward A Clark
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

6.  DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

Authors:  Gunnveig Grodeland; Siri Mjaaland; Kenneth H Roux; Agnete Brunsvik Fredriksen; Bjarne Bogen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 7.  Controlling immune responses by targeting antigens to dendritic cell subsets and B cells.

Authors:  Craig P Chappell; Natalia V Giltiay; Christiane Dresch; Edward A Clark
Journal:  Int Immunol       Date:  2013-11-27       Impact factor: 4.823

8.  Immunization procedures for E. coli proteins.

Authors:  V R Anicetti; M A Simonetti; L L Blackwood; A J Jones; A B Chen
Journal:  Appl Biochem Biotechnol       Date:  1989-11       Impact factor: 2.926

Review 9.  Warner-Lambert/Parke-Davis award lecture. Cellular interactions in the immune response. The roles of B lymphocytes and interleukin-4.

Authors:  A K Abbas
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

10.  Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs.

Authors:  Joao N Duarte; Juan J Cragnolini; Lee Kim Swee; Angelina M Bilate; Justin Bader; Jessica R Ingram; Ali Rashidfarrokhi; Tao Fang; Ariën Schiepers; Leo Hanke; Hidde L Ploegh
Journal:  J Immunol       Date:  2016-11-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.